Retatrutide has emerged as a highly promising peptide in metabolic health research. As a novel triple agonist targeting GLP-1, GIP, and glucagon receptors, it represents a significant advancement in the
Novel trend in the pharmaceutical industry is the design and development of biomolecular therapeutics for curative purposes. Peptides and proteins are naturally occurring large molecules consisting of amino acids that